Edge Therapeutics Inc. | Key People and Executives
Brian A. Leuthner
President, Chief Executive Officer & Director
Rosemary A. Crane
Independent Director
Liam Ratcliffe
Independent Director
Robert Jay Spiegel
Independent Director
James J. Loughlin
Independent Director
Isaac Blech
Vice Chairman
Brian A. Leuthner
President, Chief Executive Officer & Director
Andrew Saik
Chief Financial Officer
Herbert J. Faleck
Chief Medical Officer
Albert N. Marchio
Chief Accounting & Administrative Officer
Gregory W. Gin
Investor Relations Contact
W. Bradford Middlekauff
Secretary, Senior Vice President & General Counsel
Alyssa Wyant
Senior Vice President-Regulatory Affairs
Rosemary A. Crane
Independent Director
Liam Ratcliffe
Independent Director
Robert Jay Spiegel
Independent Director
James J. Loughlin
Independent Director
Isaac Blech
Vice Chairman
| Address |
300 Connell Drive
Berkeley Heights New Jersey 07922
United States
|
|
Employees
|
- |
| Website |
http://www.edgetherapeutics.com |
| Updated |
09/14/2018 |
| Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. |
